A new JAMA Oncology study from Memorial Sloan Kettering Cancer Center finds that risk-adjusted Medicare claims data -- without information about the cancer stage of individual patients -- may be sufficient to calculate the long-term survival rates at hospitals providing cancer care in the United States.
Cornell University, in partnership with Memorial Sloan Kettering Cancer Center (MSKCC), is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.
Craig B. Thompson leads one of the country's most prestigious cancer hospitals, Memorial Sloan Kettering Cancer Center in New York. But noticeably absent from his online biographical sketch is his position as a director of one of the world’s biggest pharmaceutical companies, Merck, where over the past four years, he's received more than $1 million to serve on […]
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients' tumors rather than where their cancer originated.
Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.
Chambers Street Properties, a real estate investment trust, has sold a Montvale, N.J., property to a subsidiary of Memorial Sloan Kettering Cancer Center for $37 million. The 142,500-square-foot... To view the full story, click the title link.
Pereira & O’Dell New York unveiled the next phase of its “More science. Less fear.” campaign for Memorial Sloan Kettering Cancer Center, which launched last September, marking the agency’s first effort for the client since winning agency of record duties in February, 2014. Show More Summary
Giving people a new way to think and talk about cancer." That's the mission of three Internet films from New York's Memorial Sloan Kettering Cancer Center, according to chief communications officer Avice Meehan. "We started to frameShow More Summary
Statins have been shown to reduce complications from cardiovascular surgery. To determine whether statins might also help those undergoing major lung surgeries, a team at Memorial Sloan Kettering Cancer Center conducted a well-designed study that randomized patients to receive either a statin or placebo before and after surgery. Show More Summary
Roger Daltrey, the Rock And Roll Hall Of Fame crooner, was in New York this week. Yes, it was for The Who’s 50th Anniversary Tour but, as importantly, the rock icon was checking progress on a teen cancer center being developed at Memorial Sloan Kettering. In 2012, Daltrey and Elvis [...]
Memorial Sloan Kettering Cancer Center (MSK) introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical...Show More Summary
Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
CBS News medical contributor Dr. David Agus speaks with Dr. Jose Baselga, physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center, about the future of cancer treatment and genome mapping.
The effort --- a partnership with Memorial Sloan Kettering Cancer Center --- is said to detect the disease with 97 percent accuracy.
A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.
THR reports that actress Elizabeth Norment, most recently seen playing Frank Underwood’s secretary Nancy on House of Cards, passed away on October 13th at the Sloan Kettering Cancer Center. She was 61. A staple of the Southern California theater scene, Norment also appeared in a number of film and television... More »
House of Cards actress Elizabeth Norment has died. The actress was 61 years old and passed away on October 13 at Memorial Sloan Kettering Cancer Center. Her sister Kate confirmed the sad news to The Hollywood Reporter. As some of you...Show More Summary
House of Cards actress Elizabeth Norment has passed away at the age of 61. She died October 13 at Memorial Sloan Kettering Cancer Center in New York, according to her family. Further details about her death are not yet known. Norment's...Show More Summary
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer treatment.
Andrew Madoff died at Sloan Kettering Cancer Center, his lawyer told CNBC. Andrew was never charged criminally as part of his father's multi-billion dollar Ponzi scheme.